When was Altos Labs founded?

Altos Labs was founded in 2021.

Where is Altos Labs located?

Altos Labs is headquartered in Redwood City, United States.

How many employees does Altos Labs have?

As of Apr 30, 2026, the latest employee count at Altos Labs is 565.

Is Altos Labs a funded company?

Altos Labs is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Altos Labs rank among its competitors?

Altos Labs ranks 21st amongst 91 active competitors, of which 26 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Life Biosciences, which secured $80M in Apr, 2026.

Who are the top competitors of Altos Labs?

Altos Labs' top competitors include Tenaya Therapeutics, Tune Therapeutics and Orca Bio. Among them, Life Biosciences secured the most recent funding round in April, 2026.

Altos Labs - 2026 Company Profile, Team, Funding & Competitors

Altos Labs is a funded company based in Redwood City (United States), founded in 2021 by Hans Bishop, Anabey Camarena and Rick Klauser. It operates as a Lab conducting research on cellular rejuvenation programming to restore cell health and resilience. The company has 91 active competitors, including 26 funded and 19 that have exited. Its top competitors include companies like Tenaya Therapeutics, Tune Therapeutics and Orca Bio.

Company Details

The company aims to understand cellular rejuvenation to improve overall health.

Website: www.altoslabs.com/
Social
Email ID: *****@altoslabs.com

Key Metrics

Founded Year

2021

Location

Redwood City, United States

Stage

Funding Raised

Investors

Foresite Capital & 4 more

Ranked

21^st among 91 active competitors

Employee Count

565 as on Apr 30, 2026

Investment & Acquisitions

Dorian Therapeutics

Similar Companies

Tenaya Therapeutics & 112 more

View Altos Labs' full profile

Altos Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Altos Labs, Inc. CIN: 863736536 , United States, Active	Dec 31, 1999	-	409 (As on Dec 31, 2024)	-

Altos Labs is a funded company. Altos Labs has 5 institutional investors.

View details of Altos Labs's funding rounds and investors

The founders of Altos Labs are Hans Bishop, Anabey Camarena and Rick Klauser.

Here are the details of Altos Labs' key team members:

Hans Bishop: Co-Founder of Altos Labs. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Anabey Camarena: Co-Founder of Altos Labs.
Contact Info: 1 email address
Rick Klauser: Co-Founder of Altos Labs.

View details of Altos Labs's Founder profiles and Board Members

Altos Labs' employee count trend

Altos Labs has 565 employees as of Apr 26. Here is Altos Labs's employee count trend over the years:

Uncover Altos Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Altos Labs include Tenaya Therapeutics, Tune Therapeutics and Orca Bio. Here is the list of Top 10 competitors of Altos Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tenaya Therapeutics 2016, San Francisco (United States), Public	Developer of regenerative and gene therapeutics for heart failure	$248M	Fidelity Investments, RTW Investments & 7 others	70/100
2nd	Tune Therapeutics 2009, Seattle (United States), Series B	Developer of cell and gene therapy by using the epigenomic platform	$222M	New Enterprise Associates, Emerson Collective ... & 8 others	63/100
3rd	Orca Bio 2016, Menlo Park (United States), Series F	Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders	$300M	Lightspeed Venture Partners, Mubadala & 11 others	63/100
4th	Life Biosciences 2017, Boston (United States), Series D	Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases	$261M	Alpha Wave Global, Globalive Capital & 13 others	61/100
5th	LIfT Biosciences 2016, London (United Kingdom), Series A	Developer of neutrophil-based cell therapies for solid tumors	$20.1M	Kizoo, Downing & 13 others	61/100
6th	Athira Pharma 2011, Seattle (United States), Public	Developer of drugs for neurodegenerative diseases	$121M	Dolby Family Ventures, Alzheimer's Drug Discovery ... & 22 others	60/100
7th	Avita Medical 1992, Cambridge (United Kingdom), Public	Regenerative and Respiratory Medicine product company	-	BioScience Managers, Orbimed & 6 others	59/100
8th	Orthofix 1980, Lewisville (United States), Public	Developer of reconstructive and regenerative solutions for bone-related conditions	-	-	59/100
9th	Organogenesis 1985, Canton (United States), Public	Regenerative tissue innovations for advanced wound care and surgical solutions	$30M	Eastward Capital Partners, Spring St. Group ... & 2 others	59/100
10th	Retro 2020, Redwood City (United States), Series D	Developer of therapeutics targeting cellular mechanisms to treat aging diseases	$180M	-	57/100
21st	Altos Labs 2021, Redwood City (United States), Funding Raised	Lab conducting research on cellular rejuvenation programming to restore cell health and resilience	-	Foresite Capital, General Catalyst & 3 others	47/100